EBAG9 has been found to be related to the pathophysiology of a variety of cancers, such as HCC, pancreatic cancer, and RCC [83–87], and has likewise been found to promote tumor progression and metastasis by inhibiting the cytotoxicity of immune cells [88]. This evidence concerns the gene EBAG9 and neoplasm.